IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Patient Case A 23-year-old biology PhD candidate presents for further evaluation of her gastrointestinal (GI) symptoms (Table 1). These symptoms have been present for the past […]
Abstract: Ulcerative colitis and Crohn’s disease are chronic, progressive inflammatory bowel diseases (IBDs) and are without a known cure. Janus kinase (JAK) is a family of […]
Patient Case A 43-year-old White male with metabolic syndrome presented with complaints of fatigue and feeling distracted. Blood work showed a mild increase in aspartate aminotransferase […]
Abstract: Portal hypertension leads to the formation of portosystemic collaterals that divert portal blood to the systemic circulation and bypass the liver, resulting in multiple severe […]
A Review of Selected Presentations From ACG 2022 October 21-26, 2022 • Charlotte, North Carolina Duration of Response to Ozanimod After Treatment Withdrawal: Results From the […]
A Review of Selected Presentations From DDW 2022 • May 21-24, 2022 • San Diego, California Recapture of Response With Ozanimod in Patients With Moderately […]
Rapidity of Ozanimod-Induced Symptomatic Response and Remission in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Induction Period of True North Ozanimod is […]
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. It represents a spectrum of disease from simple hepatic steatosis to steatohepatitis […]
Abstract: Consultation for liver disease during pregnancy is challenging for both the hepatologist and gynecologist, as normal physiologic changes during pregnancy can mimic chronic liver disease. […]
Abstract: Renal dysfunction frequently develops in patients with advanced liver disease. Renal dysfunction in this setting is associated with adverse outcomes and an unfavorable prognosis. Hepatorenal […]